{"nodes": [{"id": "molecular dynamics"}, {"id": "acid diethylamide"}, {"id": "altered states"}, {"id": "human serotonin"}, {"id": "intranasal ot"}, {"id": "healthy participants"}, {"id": "selective cb2"}, {"id": "oral lsd"}, {"id": "mystical experiences"}, {"id": "psychotic-like effects"}, {"id": "subjective effects"}, {"id": "5\u2032-promoter exists"}, {"id": "prototypical hallucinogen"}, {"id": "spiritual experiences"}, {"id": "functional connectivity"}, {"id": "hallucinogenic properties"}, {"id": "5-ht2a receptors"}, {"id": "visual drug"}, {"id": "variable number"}, {"id": "visceral hypersensitivity"}, {"id": "hallucinogenic drugs"}, {"id": "sensory representations"}, {"id": "d-lysergic acid"}, {"id": "prefrontal cortex"}, {"id": "5d-asc scale"}, {"id": "non-competitive inhibitor"}, {"id": "subjective anxiety"}, {"id": "LSD"}, {"id": "psychotic-like states"}, {"id": "preclinical research"}, {"id": "polymorphic region"}, {"id": "ot-related genotypes"}, {"id": "5-ht2a receptor"}, {"id": "diethylamide lsd"}, {"id": "exposure\u2013response relationship"}, {"id": "pharmacological tools"}, {"id": "pre-registered sought"}, {"id": "psilocybin-assisted psychotherapy"}, {"id": "cannabinoid receptors"}, {"id": "inward-facing conformation"}, {"id": "plasma concentration"}, {"id": "molecular mechanism"}, {"id": "single dose"}, {"id": "high doses"}], "links": [{"source": "5d-asc scale", "target": "psilocybin-assisted psychotherapy", "value": 10}, {"source": "mystical experiences", "target": "mystical experiences", "value": 10}, {"source": "5d-asc scale", "target": "altered states", "value": 10}, {"source": "LSD", "target": "acid diethylamide", "value": 10}, {"source": "5-ht2a receptor", "target": "visceral hypersensitivity", "value": 10}, {"source": "human serotonin", "target": "polymorphic region", "value": 10}, {"source": "psychotic-like effects", "target": "d-lysergic acid", "value": 10}, {"source": "mystical experiences", "target": "ot-related genotypes", "value": 10}, {"source": "psychotic-like effects", "target": "high doses", "value": 10}, {"source": "acid diethylamide", "target": "oral lsd", "value": 10}, {"source": "5d-asc scale", "target": "hallucinogenic drugs", "value": 10}, {"source": "5-ht2a receptor", "target": "prefrontal cortex", "value": 10}, {"source": "5d-asc scale", "target": "functional connectivity", "value": 10}, {"source": "mystical experiences", "target": "subjective effects", "value": 10}, {"source": "acid diethylamide", "target": "pharmacological tools", "value": 10}, {"source": "LSD", "target": "5d-asc scale", "value": 10}, {"source": "5d-asc scale", "target": "visual drug", "value": 10}, {"source": "5d-asc scale", "target": "subjective anxiety", "value": 10}, {"source": "5-ht2a receptor", "target": "selective cb2", "value": 10}, {"source": "mystical experiences", "target": "spiritual experiences", "value": 10}, {"source": "acid diethylamide", "target": "subjective effects", "value": 10}, {"source": "LSD", "target": "5-ht2a receptor", "value": 10}, {"source": "psychotic-like effects", "target": "hallucinogenic properties", "value": 10}, {"source": "5-ht2a receptor", "target": "cannabinoid receptors", "value": 10}, {"source": "mystical experiences", "target": "intranasal ot", "value": 10}, {"source": "LSD", "target": "mystical experiences", "value": 10}, {"source": "5-ht2a receptor", "target": "5-ht2a receptors", "value": 10}, {"source": "mystical experiences", "target": "pre-registered sought", "value": 10}, {"source": "5-ht2a receptor", "target": "molecular mechanism", "value": 10}, {"source": "mystical experiences", "target": "single dose", "value": 10}, {"source": "5-ht2a receptor", "target": "5-ht2a receptor", "value": 10}, {"source": "acid diethylamide", "target": "diethylamide lsd", "value": 10}, {"source": "human serotonin", "target": "variable number", "value": 10}, {"source": "acid diethylamide", "target": "exposure\u2013response relationship", "value": 10}, {"source": "acid diethylamide", "target": "plasma concentration", "value": 10}, {"source": "human serotonin", "target": "molecular dynamics", "value": 10}, {"source": "psychotic-like effects", "target": "psychotic-like states", "value": 10}, {"source": "psychotic-like effects", "target": "preclinical research", "value": 10}, {"source": "human serotonin", "target": "5\u2032-promoter exists", "value": 10}, {"source": "LSD", "target": "psychotic-like effects", "value": 10}, {"source": "LSD", "target": "human serotonin", "value": 10}, {"source": "human serotonin", "target": "human serotonin", "value": 10}, {"source": "psychotic-like effects", "target": "sensory representations", "value": 10}, {"source": "acid diethylamide", "target": "psychotic-like effects", "value": 10}, {"source": "human serotonin", "target": "non-competitive inhibitor", "value": 10}, {"source": "5d-asc scale", "target": "healthy participants", "value": 10}, {"source": "human serotonin", "target": "inward-facing conformation", "value": 10}, {"source": "LSD", "target": "prototypical hallucinogen", "value": 10}, {"source": "psychotic-like effects", "target": "psychotic-like effects", "value": 10}]}